Literature DB >> 16757691

Lung cancer screening, overdiagnosis bias, and reevaluation of the Mayo Lung Project.

Edward F Patz.   

Abstract

Entities:  

Mesh:

Year:  2006        PMID: 16757691     DOI: 10.1093/jnci/djj226

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  9 in total

1.  Reporting instructions significantly impact false positive rates when reading chest radiographs.

Authors:  John W Robinson; Patrick C Brennan; Claudia Mello-Thoms; Sarah J Lewis
Journal:  Eur Radiol       Date:  2016-01-15       Impact factor: 5.315

2.  National Lung Cancer Screening Trial American College of Radiology Imaging Network Specimen Biorepository originating from the Contemporary Screening for the Detection of Lung Cancer Trial (NLST, ACRIN 6654): design, intent, and availability of specimens for validation of lung cancer biomarkers.

Authors:  Edward F Patz; Neil E Caporaso; Steven M Dubinett; Pierre P Massion; Fred R Hirsch; John D Minna; Constantine Gatsonis; Fenghai Duan; Amanda Adams; Charles Apgar; Rosa M Medina; Denise R Aberle
Journal:  J Thorac Oncol       Date:  2010-10       Impact factor: 15.609

Review 3.  Update in lung cancer 2006.

Authors:  Sarita Dubey; Charles A Powell
Journal:  Am J Respir Crit Care Med       Date:  2007-05-01       Impact factor: 21.405

4.  Low-dose CT screening in an Asian population with diverse risk for lung cancer: A retrospective cohort study.

Authors:  Chin A Yi; Kyung Soo Lee; Myung-Hee Shin; Yun Yung Cho; Yoon-Ho Choi; O Jung Kwon; Kyung Eun Shin
Journal:  Eur Radiol       Date:  2015-02-14       Impact factor: 5.315

5.  Overdiagnosis in low-dose computed tomography screening for lung cancer.

Authors:  Edward F Patz; Paul Pinsky; Constantine Gatsonis; Jorean D Sicks; Barnett S Kramer; Martin C Tammemägi; Caroline Chiles; William C Black; Denise R Aberle
Journal:  JAMA Intern Med       Date:  2014-02-01       Impact factor: 21.873

6.  Moving beyond the national lung screening trial: discussing strategies for implementation of lung cancer screening programs.

Authors:  Bernardo H L Goulart; Scott D Ramsey
Journal:  Oncologist       Date:  2013-07-19

7.  Assessing the extent of non-aggressive cancer in clinically detected stage I non-small cell lung cancer.

Authors:  Minal S Kale; Keith Sigel; Grace Mhango; Juan P Wisnivesky
Journal:  Thorax       Date:  2017-10-20       Impact factor: 9.139

8.  Modeling excess lung cancer risk among screened arm participants in the Mayo Lung Project.

Authors:  Deborah L Goldwasser; Marek Kimmel
Journal:  Cancer       Date:  2010-01-01       Impact factor: 6.860

9.  Cost of a 5-year lung cancer survivor: symptomatic tumour identification vs proactive computed tomography screening.

Authors:  A W Castleberry; D Smith; C Anderson; A J Rotter; F W Grannis
Journal:  Br J Cancer       Date:  2009-08-18       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.